Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Beginning Balance at Dec. 31, 2019 $ 152,685 $ 11,119 $ 103,124 $ 38,442
Beginning Balance (in shares) at Dec. 31, 2019   15,263    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 5,905     5,905
Vesting of restricted stock (73) $ (8) (65)  
Vesting of restricted stock (in shares)   27    
Stock-based compensation expense 95 $ 10 85  
Ending Balance at Mar. 31, 2020 158,612 $ 11,121 103,144 44,347
Ending Balance (in shares) at Mar. 31, 2020   15,290    
Beginning Balance at Dec. 31, 2019 152,685 $ 11,119 103,124 38,442
Beginning Balance (in shares) at Dec. 31, 2019   15,263    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (11,969)      
Ending Balance at Sep. 30, 2020 141,423 $ 11,189 103,761 26,473
Ending Balance (in shares) at Sep. 30, 2020   15,325    
Beginning Balance at Mar. 31, 2020 158,612 $ 11,121 103,144 44,347
Beginning Balance (in shares) at Mar. 31, 2020   15,290    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (5,537)     (5,537)
Vesting of restricted stock (1)   (1)  
Vesting of restricted stock (in shares)   19    
Stock-based compensation expense 345 $ 34 311  
Ending Balance at Jun. 30, 2020 153,419 $ 11,155 103,454 38,810
Ending Balance (in shares) at Jun. 30, 2020   15,309    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (12,337)     (12,337)
Vesting of restricted stock (in shares)   16    
Stock-based compensation expense 341 $ 34 307  
Ending Balance at Sep. 30, 2020 141,423 $ 11,189 103,761 26,473
Ending Balance (in shares) at Sep. 30, 2020   15,325    
Beginning Balance at Dec. 31, 2020 $ 126,362 $ 11,223 104,072 11,067
Beginning Balance (in shares) at Dec. 31, 2020 15,359 15,359    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ (18,641)     (18,641)
Vesting of restricted stock (100) $ (9) (91)  
Vesting of restricted stock (in shares)   158    
Stock-based compensation expense 313 $ 31 282  
Ending Balance at Mar. 31, 2021 107,934 $ 11,245 104,263 (7,574)
Ending Balance (in shares) at Mar. 31, 2021   15,517    
Beginning Balance at Dec. 31, 2020 $ 126,362 $ 11,223 104,072 11,067
Beginning Balance (in shares) at Dec. 31, 2020 15,359 15,359    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ (16,280)      
Ending Balance at Sep. 30, 2021 $ 111,154 $ 11,331 105,036 (5,213)
Ending Balance (in shares) at Sep. 30, 2021 15,552 15,552    
Beginning Balance at Mar. 31, 2021 $ 107,934 $ 11,245 104,263 (7,574)
Beginning Balance (in shares) at Mar. 31, 2021   15,517    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (2,951)     (2,951)
Vesting of restricted stock (8) $ (1) (7)  
Vesting of restricted stock (in shares)   18    
Stock-based compensation expense 364 $ 37 327  
Ending Balance at Jun. 30, 2021 105,339 $ 11,281 104,583 (10,525)
Ending Balance (in shares) at Jun. 30, 2021   15,535    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 5,312     5,312
Vesting of restricted stock (in shares)   17    
Stock-based compensation expense 503 $ 50 453  
Ending Balance at Sep. 30, 2021 $ 111,154 $ 11,331 $ 105,036 $ (5,213)
Ending Balance (in shares) at Sep. 30, 2021 15,552 15,552